Tarnagulla Ventures

General contacts
Investor type

VC

Founded

2015

AUM

-

Location

Melbourne, Victoria, Australia

Investment Ticket

$0-1 m

Investment Stage

Seed Series A

Region of investment

North America Australia and others
Investor profile last updated: 21 August, 2026

Profile

Tarnagulla Ventures is a venture capital firm based in Melbourne, Australia, focusing on life sciences and healthcare. The firm is managed by William and Natalie McNamee and operates on a global scale, concentrating on bringing promising medical technologies to the Australian and US markets. Tarnagulla Ventures differentiates itself by providing not only financial capital but also strategic support to its portfolio companies, leveraging its expertise in life sciences.

Tarnagulla Ventures primarily invests in seed and early-stage companies within the life sciences sector, including small molecules, protein, and cell-based therapeutics. Their investment strategy involves making less frequent but more concentrated investments to devote time and resources to support their companies. Although based in Australia, they predominantly invest in US-based companies. The firm operates with the philosophy of value investing, nurturing long-term partnerships with its investees.

Notable investments by Tarnagulla Ventures include Jupiter Neurosciences, Azora Therapeutics, Prevatex, Lubris, Inversago, Nacuity, and LB Pharma. The firm is recognized for its ability to identify successful investment opportunities in breakthrough life science technologies.

Industry

HealthTech Life Sciences Pharmaceuticals Healthcare Services Medical Devices

Contacts

Name
Title
Email
Social Networks
avatar
Natalie McNamee Director
Director
n•••@•••
avatar
William McNamee Director
Director
-
LinkedIn
Upgrade to see contacts
avatar
xyzMSRvKYq0tDX17 xyzMSRvKYq0tDX17
xyzMSRvKYq0tDX17
[email protected]
linkedin twitter
avatar
xyzMSRvKYq0tDX17 xyzMSRvKYq0tDX17
xyzMSRvKYq0tDX17
[email protected]
linkedin twitter
avatar
xyzMSRvKYq0tDX17 xyzMSRvKYq0tDX17
xyzMSRvKYq0tDX17
[email protected]
linkedin twitter
Investment-team contacts for Tarnagulla Ventures — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Tarnagulla Ventures

Tarnagulla Ventures is a venture capital firm. It backs companies at Seed and Series A, writing tickets of $0-1 m.
Tarnagulla Ventures is located in Melbourne, Victoria, Australia.
Tarnagulla Ventures was founded in 2015.
Tarnagulla Ventures invests in companies and startups in HealthTech, Life Sciences, Pharmaceuticals, Healthcare Services, Medical Devices.
Tarnagulla Ventures invests in companies and startups in North America, Australia and others.
Tarnagulla Ventures invests in companies and startups at Seed, Series A.
Tarnagulla Ventures usually invests $0-1 m on average.
Tarnagulla Ventures can be reached through its website tarnagullaventures.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Tarnagulla Ventures — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Tarnagulla Ventures directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 21 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.